A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients with Triple-Negative Locally Advanced Breast Cancer

Grant

Awarded By

Total Award Amount

  • 43644.00

    • Direct Costs

  • 34635.00

    • Sponsor Award Id

    • Contributor

  • John Carpenter   Principal Investigator